LONDON--(BUSINESS WIRE)--A well-known market intelligence company, Infiniti Research, has announced the completion of their recent article on common mistakes to avoid in your product positioning ...
Formulation complexity, especially in small molecule drugs, has been getting more attention as capabilities continue to ...
Every day we can read about the latest artificial-intelligence advances from research labs, startups and large companies. AI technologies are approaching or surpassing human levels of performance in ...
The latest Dietary Guidelines may not reinvent the wheel, but they offer manufacturers a roadmap to balance nutrition, consumer preference and formulation strategy across sweeteners, grains and ...
Data management is increasingly falling within the purview of the modern CMO. But with the advent of CCPA and the consequences felt as a result of GDPR (to say nothing of future potential privacy ...
Over the last several years, we have seen the return of large patent infringement verdicts and verdicts that have also enhanced damages for willful infringement. These verdicts have not gone unnoticed ...
The widely spread traditional strategy approach as we know it relies strongly on gathering and analyzing data. With the help of frameworks like Porter's Five Forces Framework and the DESTEP analysis, ...
Exit evaluation is a key criterion for any serious investor while evaluating an investment and continues to be a key focus area post-investment A good exit track record is crucial for the investor to ...
Early on, the drug substance (DS) manufacturer will provide a wealth of preliminary characterization data. And if the drug is active in early nonclinical and preclinical testing, a larger quantity of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results